Taro Pharmaceuticals
TAROPrivate Company
Funding information not available
Overview
Taro Pharmaceuticals is a mission-driven generic drug manufacturer focused on providing affordable, high-quality medications, with a recognized leadership position in topical dermatology. Its strategic achievements include successful integration into Sun Pharma's global network, providing R&D and financial scale, and the expansion of its product portfolio into high-volume therapeutic areas like cardiology. The company's strategy centers on leveraging its complex formulation platform to differentiate its generic offerings and capitalize on stable market demand for cost-effective therapeutics.
Technology Platform
A platform centered on complex formulation science, bioequivalence testing, and robust manufacturing processes for generic topical dermatological products and oral solid dosage forms.
FDA Approved Drugs
47Opportunities
Risk Factors
Competitive Landscape
Taro competes in dermatology against specialized generic firms like Perrigo, where its formulation expertise is a moat. In oral solids, it faces intense price competition from large global generics players (Teva, Viatris) and low-cost manufacturers. Its integration with Sun Pharma provides cost and supply chain advantages.